Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001493152-19-018758
Filing Date
2019-12-05
Accepted
2019-12-04 21:54:00
Documents
1
Effectiveness Date
2019-12-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9805
  Complete submission text file 0001493152-19-018758.txt   11226
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-352091 | Film No.: 191269373
SIC: 7389 Services-Business Services, NEC